Axcella Health Inc (AXLA)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track Share on 𝕏

Stock chart
Ticker: AXLA Exchange: NMS


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale
Past 90 days
 
Value bought
 
Value sold
 
Net insiders buying
 
Trades (buy and sell)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Total value Details
2023-03-03 2023-03-01 PS Planned sale

Koziel Margaret

Chief Medical Officer

Officer
679 -2.7%
0.58
394 USD 		679 -2.7% 0.58 394 USD
2022-10-19 2022-10-19 S Sale

Hinshaw William

President & CEO

Executive Director
16,000 -16.3%
1.56
25,027 USD 		16,000 -16.3% 1.56 25,027 USD
2022-10-17 2022-10-13 B Purchase

Societe des Produits Nestle S.A.

Major owner
3,658,536 +49.1%
1.64
5,999,999 USD 		3,658,536 +49.1% 1.64 5,999,999 USD
2022-10-17 2022-10-13 B Purchase

Flagship Ventures Fund IV General Partner LLC

Major owner
3,048,780 +inf%
1.64
4,999,999 USD 		3,048,780 +inf% 1.64 4,999,999 USD
2022-10-17 2022-10-13 B Purchase

Flagship Ventures Fund IV General Partner LLC

Major owner
919,111 +17.1%
1.64
1,507,342 USD 		919,111 +17.1% 1.64 1,507,342 USD
2022-10-17 2022-10-13 B Purchase

Flagship Ventures Fund IV General Partner LLC

Major owner
914,634 +20.5%
1.64
1,500,000 USD 		914,634 +20.5% 1.64 1,500,000 USD
2022-10-17 2022-10-13 B Purchase

Flagship Ventures Fund IV General Partner LLC

Major owner
2,757,333 +24.3%
1.64
4,522,026 USD 		2,757,333 +24.3% 1.64 4,522,026 USD
2022-10-17 2022-10-13 B Purchase

Flagship Ventures Fund IV General Partner LLC

Major owner
2,743,902 +31.9%
1.64
4,499,999 USD 		2,743,902 +31.9% 1.64 4,499,999 USD
2022-09-08 2022-09-06 S Sale

Koziel Margaret

Chief Medical Officer

Officer
547 -2.1%
2.52
1,378 USD 		547 -2.1% 2.52 1,378 USD
2022-06-02 2022-06-01 S Sale

Koziel Margaret

Chief Medical Officer

Officer
590 -2.2%
2.01
1,186 USD 		590 -2.2% 2.01 1,186 USD
2022-03-18 2022-03-16 B Purchase

Epstein David R

Non-Executive Director
26,178 +19.4%
1.91
50,000 USD 		26,178 +19.4% 1.91 50,000 USD
2022-03-18 2022-03-16 B Purchase

Flagship Ventures Fund IV General Partner LLC

Major owner
1,579,843 +54.7%
1.91
3,017,500 USD 		1,579,843 +54.7% 1.91 3,017,500 USD
2022-03-18 2022-03-16 B Purchase

Flagship Ventures Fund IV General Partner LLC

Major owner
947,905 +89.7%
1.91
1,810,499 USD 		947,905 +89.7% 1.91 1,810,499 USD
2022-03-18 2022-03-16 B Purchase

Flagship Ventures Fund IV General Partner LLC

Major owner
3,791,623 +78.8%
1.91
7,242,000 USD 		3,791,623 +78.8% 1.91 7,242,000 USD
2022-03-18 2022-03-16 B Purchase

Fehlner Paul

SVP & Chief Legal Officer

Officer
10,471 +101.4%
1.91
20,000 USD 		10,471 +101.4% 1.91 20,000 USD
2022-03-18 2022-03-16 B Purchase

Crane Robert

Chief Financial Officer

Officer
39,267 +inf%
1.91
75,000 USD 		39,267 +inf% 1.91 75,000 USD
2022-03-18 2022-03-16 B Purchase

Hinshaw William

President & CEO

Executive Director
13,089 +37.5%
1.91
25,000 USD 		13,089 +37.5% 1.91 25,000 USD
2022-03-16 2022-03-16 B Purchase

Societe des Produits Nestle S.A.

Major owner
3,141,361 +73.0%
1.91
6,000,000 USD 		3,141,361 +73.0% 1.91 6,000,000 USD
2022-03-03 2022-03-01 S Sale

Koziel Margaret

Chief Medical Officer

Officer
553 -2.0%
1.86
1,030 USD 		553 -2.0% 1.86 1,030 USD
2022-02-01 2022-01-31 S Sale

Hinshaw William

President and CEO

Executive Director
16,590 -33.2%
1.65
27,393 USD 		16,590 -33.2% 1.65 27,393 USD
2021-02-03 2021-02-01 S Sale

Chakravarthy Manu

SVP & Chief Medical Officer

Officer
18,472 -30.8%
5.50
101,631 USD 		18,472 -30.8% 5.50 101,631 USD
2020-05-21 2020-05-18 B Purchase

Nestle Health Science US Holdings, Inc.

Major owner
1,936,842 +81.8%
4.75
9,200,000 USD 		1,936,842 +81.8% 4.75 9,200,000 USD
2020-05-20 2020-05-18 B Purchase

Flagship Ventures Fund IV General Partner LLC

Major owner
1,900,000 +192.7%
4.75
9,025,000 USD 		1,900,000 +192.7% 4.75 9,025,000 USD
2020-05-20 2020-05-18 B Purchase

Flagship Ventures Fund IV General Partner LLC

Major owner
380,000 +56.2%
4.75
1,805,000 USD 		380,000 +56.2% 4.75 1,805,000 USD
2020-05-20 2020-05-18 B Purchase

Flagship Ventures Fund IV General Partner LLC

Major owner
1,520,000 +46.2%
4.75
7,220,000 USD 		1,520,000 +46.2% 4.75 7,220,000 USD
2020-05-20 2020-05-18 B Purchase

Epstein David R

Non-Executive Director
50,000 +73.4%
4.75
237,500 USD 		50,000 +73.4% 4.75 237,500 USD
2020-03-02 2020-02-28 B Purchase

Epstein David R

Non-Executive Director
2,005 +3.0%
3.75
7,519 USD 		2,005 +3.0% 3.75 7,519 USD
2020-03-02 2020-02-27 B Purchase

Epstein David R

Non-Executive Director
12,800 +24.0%
3.65
46,720 USD 		12,800 +24.0% 3.65 46,720 USD
2020-01-31 2020-01-31 B Purchase

Chardonnet Laurent

Chief Financial Officer
3,000 +451.1%
4.94
14,820 USD 		3,000 +451.1% 4.94 14,820 USD
2020-01-28 2020-01-27 B Purchase

Chardonnet Laurent

Chief Financial Officer
352 +112.5%
4.94
1,739 USD 		352 +112.5% 4.94 1,739 USD
2020-01-28 2020-01-24 B Purchase

Chardonnet Laurent

Chief Financial Officer
313 +inf%
4.92
1,540 USD 		313 +inf% 4.92 1,540 USD
2020-01-21 2020-01-17 B Purchase

Sohn Catherine A.

1,000 +inf%
4.87
4,870 USD 		1,000 +inf% 4.87 4,870 USD
2019-12-03 2019-11-27 B Purchase

Epstein David R

Non-Executive Director
1,005 +1.9%
3.91
3,930 USD 		1,005 +1.9% 3.91 3,930 USD
2019-12-02 2019-11-27 B Purchase

Epstein David R

Non-Executive Director
1,005 +1.9%
3.91
3,930 USD 		1,005 +1.9% 3.91 3,930 USD
2019-12-03 2019-11-26 B Purchase

Epstein David R

Non-Executive Director
14,000 +36.6%
3.55
49,700 USD 		14,000 +36.6% 3.55 49,700 USD
2019-12-02 2019-11-26 B Purchase

Epstein David R

Non-Executive Director
14,000 +36.6%
3.55
49,700 USD 		14,000 +36.6% 3.55 49,700 USD
2019-08-05 2019-08-02 B Purchase

Epstein David R

Non-Executive Director
2,849 +8.0%
7.04
20,057 USD 		2,849 +8.0% 7.04 20,057 USD
2019-08-05 2019-08-01 B Purchase

Epstein David R

Non-Executive Director
4,092 +13.1%
6.98
28,562 USD 		4,092 +13.1% 6.98 28,562 USD
2019-07-18 2019-07-17 B Purchase

Epstein David R

1,000 +3.3%
7.55
7,550 USD 		1,000 +3.3% 7.55 7,550 USD
2019-07-10 2019-07-10 B Purchase

Epstein David R

1,322 +4.6%
8.07
10,669 USD 		1,322 +4.6% 8.07 10,669 USD
2019-07-10 2019-07-09 B Purchase

Epstein David R

4,200 +16.9%
8.24
34,608 USD 		4,200 +16.9% 8.24 34,608 USD
2019-07-10 2019-07-08 B Purchase

Epstein David R

274 +1.1%
9.00
2,466 USD 		274 +1.1% 9.00 2,466 USD
2019-07-03 2019-07-03 B Purchase

Epstein David R

56 +0.3%
8.99
503 USD 		56 +0.3% 8.99 503 USD
2019-07-03 2019-07-02 B Purchase

Epstein David R

3,500 +22.6%
8.77
30,678 USD 		3,500 +22.6% 8.77 30,678 USD
2019-07-03 2019-07-01 B Purchase

Epstein David R

1,000 +6.9%
8.74
8,735 USD 		1,000 +6.9% 8.74 8,735 USD
2019-07-01 2019-06-28 B Purchase

Epstein David R

5,400 +37.0%
10.04
54,216 USD 		5,400 +37.0% 10.04 54,216 USD
2019-07-01 2019-06-27 B Purchase

Epstein David R

100 +0.7%
9.15
915 USD 		100 +0.7% 9.15 915 USD
2019-06-27 2019-06-26 B Purchase

Epstein David R

14,500 +inf%
9.57
138,765 USD 		14,500 +inf% 9.57 138,765 USD
2019-05-15 2019-05-13 B Purchase

Flagship Ventures Fund IV General Partner LLC

Major owner
500,000 +102.9%
20.00
10,000,000 USD 		500,000 +102.9% 20.00 10,000,000 USD